Stories of Hope
Research
Research, people, milestones and stories from across CureSearch.
Neuroblastoma is the most common extracranial solid tumor of childhood arising within the developing nervous system. Approximately half of neuroblastoma patients are diagnosed with high-risk disease,…
Acute Myeloid leukemia (AML) is the second most common leukemia in children, and the prognosis after relapse is poor. Unlike current CAR T treatment for the…
By Holly R. Zink, MSA, ACRP Cancer in children differs from cancer in adults, from DNA alterations to tumor origin. More than 15,000 children are diagnosed…
A closer look at Dr. VanHeyst’s osteosarcoma study The current standard treatment for osteosarcoma, a bone cancer, hasn’t changed much in decades. The chemotherapy that osteosarcoma…
A closer look at Dr. Elvin Wagenblast’s AML study Leukemia is the most common type of cancer in children. Even before a child is born, genes…
Dr. Patrick Grohar receives Fight Osteosarcoma Together Super Grant to address critical, unmet need in pediatric osteosarcoma treatment Bethesda, Md. – June 6, 2023 – CureSearch for…
A closer look at Dr. David Munn’s Phase I clinical trial There is an urgent need for better treatments for kids with brain cancer. Recurrent brain…
Dr. Kristen VanHeyst of University Hospitals Rainbow Babies & Children’s receives Young Investigator award Bethesda, Md. – May 8, 2023 – CureSearch for Children’s Cancer, a…
Project will examine how and why children develop AML, the leading cause of childhood leukemia mortality Bethesda, Md. – April 20, 2023 – CureSearch for Children’s Cancer,…
Stay close to the progress
Get research news, family stories and meaningful ways to help—delivered with purpose, not clutter.
By subscribing, you agree to receive email updates from CureSearch.
Every connection to CureSearch has a story. We’d love to hear yours.
Whether you’ve hiked, given, volunteered, or lived this journey yourself, your story is part of ours.
